Malaria vaccine candidate safe and immunogenic following first-in-human trials

Press/Media

Period	14 Sep 2022

Media coverage

Title	Malaria vaccine candidate safe and immunogenic following first-in-human trials
Media name/outlet	PublicNewsTime.com
Country/Territory	United States
Date	14/09/22
URL	https://publicnewstime.com/health-news/malaria-vaccine-candidate-safe-and-immunogenic-following-first-in-human-trials/
Persons	Jason A. Regules

Title	Malaria vaccine candidate safe and immunogenic following first-in-human trials
Media name/outlet	Medical Xpress
Country/Territory	United States
Date	14/09/22
URL	https://medicalxpress.com/news/2022-09-malaria-vaccine-candidate-safe-immunogenic.html
Persons	Jason A. Regules